logo
NasdaqGS:GH logo

Guardant Health Community

NasdaqGS:GH Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author

Community Investing Ideas

GH logo
Guardant Health
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts

Medicare Coverage Of Reveal And Shield's FDA Approval Will Expand Market Reach

Key Takeaways Achieving ASP goals and expanding Medicare coverage will drive revenue growth through higher pricing and increased test volumes. Cost reduction efforts through technological transitions will improve net margins, enhancing the company's financial performance.
View narrative
US$56.85
FV
23.1% undervalued intrinsic discount
20.32%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
5 days ago author updated this narrative